Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit

by Takumi Ogawa, Koji Kashima, Yoshikazu Yuki, Mio Mejima, Shiho Kurokawa, Masaharu Kuroda, Atsushi Okazawa, Hiroshi Kiyono, Daisaku Ohta
Published 2017-07-01

Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine

by Ai Sasou, Yoshikazu Yuki, Ayaka Honma, Kotomi Sugiura, Koji Kashima, Hiroko Kozuka-Hata, Masanori Nojima, Masaaki Oyama, Shiho Kurokawa, Shinichi Maruyama, Masaharu Kuroda, Shinjiro Tanoue, Narushi Takamatsu, Kohtaro Fujihashi, Eiji Goto, Hiroshi Kiyono
Published 2021-01-01

Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial

by Yoshikazu Yuki, PhD, Masanori Nojima, MD, Osamu Hosono, MD, Hirotoshi Tanaka, ProfMD, Yasumasa Kimura, PhD, Takeshi Satoh, PhD, Seiya Imoto, ProfPhD, Satoshi Uematsu, ProfMD, Shiho Kurokawa, PhD, Koji Kashima, PhD, Mio Mejima, PhD, Rika Nakahashi-Ouchida, PhD, Yohei Uchida, MS, Takanori Marui, MS, Noritada Yoshikawa, MD, Fumitaka Nagamura, ProfMD, Kohtaro Fujihashi, ProfDDS, Hiroshi Kiyono, ProfDDS
Published 2021-09-01